Go Pro
NASDAQ:DCGO

DocGo Q2 2026 Earnings Report

DocGo logo
$0.67 +0.01 (+2.17%)
Closing price 04:00 PM Eastern
Extended Trading
$0.67 0.00 (-0.21%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DocGo EPS Results

Actual EPS
N/A
Consensus EPS
-$0.10
Beat/Miss
N/A
One Year Ago EPS
N/A

DocGo Revenue Results

Actual Revenue
N/A
Expected Revenue
$75.35 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

DocGo Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Monday, August 17, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

DocGo Earnings Headlines

SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One under $5 company's High Altitude Head Start technology could bring that down to $20,000 per launch, or $2 million across 100 missions - a 10X cost advantage. It is already flying with paying customers, but shares may not stay this cheap once Wall Street notices.tc pixel
DocGo delays quarterly SEC filing briefly
DocGo Inc.
See More DocGo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DocGo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DocGo and other key companies, straight to your email.

About DocGo

DocGo (NASDAQ:DCGO), Inc. is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging. The company also partners with public health agencies, employers, universities and event organizers to administer diagnostic testing services for COVID-19 and other infectious diseases. By integrating telehealth, remote patient monitoring and mobile diagnostic capabilities, DocGo aims to streamline access to care, reduce strain on traditional facilities and improve patient outcomes.

DocGo became a publicly traded company in June 2021 following a business combination with SPAC sponsor GigCapital3 Inc., trading on the Nasdaq under the ticker DCGO. Headquartered in Austin, Texas, the company has expanded its reach across multiple U.S. markets, including metropolitan areas in California, Florida, Texas and New York. DocGo’s on-demand approach leverages technology and logistics to enhance convenience, affordability and quality of care for both urban and rural communities.

View DocGo Profile